Sign In
Buy KMDA
$7.39
-0.120 (-1.60%)
At Close: Jun 03, 2026
Kamada Announces FDA Approval of its New In-House Rabies Virus Neutralization Testing Laboratory
07:00am, Monday, 01'st Jun 2026
REHOVOT, Israel and HOBOKEN, N.J., June 01, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for r
Kamada Q1 Earnings Call Highlights
12:07pm, Wednesday, 13'th May 2026
Kamada NASDAQ: KMDA reiterated its full-year 2026 outlook after reporting first-quarter results that management said were in line with expectations, excluding a temporary shipment delay that shifted r
Kamada Ltd. (KMDA) Q1 2026 Earnings Call Transcript
11:30am, Wednesday, 13'th May 2026
Kamada Ltd. (KMDA) Q1 2026 Earnings Call Transcript
Kamada (KMDA) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
10:30am, Wednesday, 13'th May 2026
Although the revenue and EPS for Kamada (KMDA) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street e
Kamada Reports First Quarter 2026 Financial Results and Affirms 2026 Annual Guidance; Expecting Significantly Stronger Remainder of the Year
07:00am, Wednesday, 13'th May 2026
Q1-2026 Revenue of $45.2 Million, up 3% Year-over-Year; Adjusted EBITDA of $11.6 Million, representing a Robust 26% Margin of Revenues ; Net Income of $4.1 Million, up 4% Year-over-Year Underlying Dem
Stay Ahead of the Game With Kamada (KMDA) Q1 Earnings: Wall Street's Insights on Key Metrics
10:17am, Friday, 08'th May 2026
Get a deeper insight into the potential performance of Kamada (KMDA) for the quarter ended March 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some o
Kamada to Announce First Quarter 2026 Financial Results on May 13, 2026
07:00am, Wednesday, 06'th May 2026
REHOVOT, Israel and HOBOKEN, N.J., May 06, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd.
Kamada Announces FDA Approval of its Plasma Collection Center in San Antonio, Texas
07:00am, Thursday, 26'th Mar 2026
REHOVOT, Israel and HOBOKEN, N.J., March 26, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for
Kamada Ltd. (KMDA) Q4 2025 Earnings Call Transcript
10:52am, Wednesday, 11'th Mar 2026
Kamada Ltd. (KMDA) Q4 2025 Earnings Call Transcript
Kamada (KMDA) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
10:31am, Wednesday, 11'th Mar 2026
Although the revenue and EPS for Kamada (KMDA) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Stree
Kamada (KMDA) Q4 Earnings and Revenues Miss Estimates
09:16am, Wednesday, 11'th Mar 2026
Kamada (KMDA) came out with quarterly earnings of $0.06 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.07 per share a year ago.
REHOVOT, Israel, and HOBOKEN, N.J., March 11, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for
Kamada Declares Cash Dividend of $0.25 Per Share, to be Paid in Accordance with an Adopted Annual Cash Dividend Policy
07:00am, Wednesday, 11'th Mar 2026
REHOVOT, Israel and HOBOKEN, N.J., March 11, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd.
Ahead of Kamada (KMDA) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
10:15am, Friday, 06'th Mar 2026
Besides Wall Street's top-and-bottom-line estimates for Kamada (KMDA), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quar
KMDA vs. ARGX: Which Stock Is the Better Value Option?
12:40pm, Thursday, 05'th Mar 2026
Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Kamada (KMDA) and argenex SE (ARGX). But which of these two stocks presents investors wi
